📊 Daily PA Wrap

Records and red ink shared the same tape Wednesday. The S&P 500 and Dow pushed into fresh record territory during the session, even as the S&P 500 itself slipped 0.17% to 7,723.55 (+12.61% year to date) and the Nasdaq Composite fell 0.83% to 26,363.44 (+13.46% ytd) — its first decline in five sessions — while the Russell 2000 gave back 0.59% and the VIX eased 4.18% to 15.81. Reuters tied the split to hopes that Washington and Tehran are close to a deal reopening the Strait of Hormuz to shipping, offsetting weak reactions to SpaceX and AMD's earnings; CNBC reported Treasury Secretary Scott Bessent said an agreement "could come today or tomorrow," though Al Jazeera cited a Gulf official putting the odds at roughly 50-50 by Friday.

AMD forecast quarterly revenue above Street estimates on strong AI demand but still fell 7.04%, its steepest S&P 500 decline, as investors wanted a stronger outlook; SpaceX slumped again, erasing its prior session's gain even after narrower operating losses and a revenue beat, as forecasts of surging AI-infrastructure spending overshadowed the print. Materials (+1.48%) and Health Care (+1.44%) led sectors — Newmont jumped 6.71% as gold spiked 6.13% to $4,346.50, and Eli Lilly rose 4.86% on Mounjaro and Zepbound demand — while Energy (-2.04%) and Information Technology (-1.15%) lagged as WTI crude fell 1.11% to $74.93. Alphabet slid roughly 4% (GOOGL -4.03%, GOOG -4.05%) after chief scientist Jeff Dean's exit to launch his own company, a move FX Leaders tied to an AI-capex guidance raise investors read as pressuring free cash flow.

The beat-but-cut pattern showed up hardest in healthcare: Insulet sank 20.12% and DaVita tumbled 17.24%, both despite beating on revenue and EPS. Insulet trimmed its full-year Omnipod sales outlook, per Benzinga, while DaVita only reaffirmed rather than raised full-year guidance amid rising patient-care costs, per TheStreet — this earnings season, the market is pricing the guide, not the quarter.

Gold's jump and oil's slide traced back to the same Hormuz catalyst cutting two ways, per Watcher.Guru: softer near-term inflation expectations pulling forward hopes for easier Fed policy, even as Chair Kevin Warsh reiterated last week that "there is no soft inflation target," per CNBC, and the market's own implied path keeps drifting toward 3.94% by January rather than lower. Our take: dispersion, not conviction, defined the session — earnings were rewarded only where guidance matched the beat, and today's record headline levels are masking a market still working out whether the Hormuz story and the AI-capex story can keep paying off at the same time. Friday's Employment Situation report is the next real test.

Credit and rates read calmer than the equity dispersion suggests: the 10-year yield eased 7bp to 4.63% and HY OAS tightened 5bp to 2.73 (both as of Aug 4), even as the market's implied Fed path keeps drifting higher — from 3.63% this month to 3.94% by January 2027 — consistent with Chair Warsh's hawkish framing.

Breadth turned negative again (245 advancers, 258 decliners, average -0.22%) after Tuesday's sharply positive session, though longer-run technicals held steady — 67.6% of S&P 500 members trade above their 50-day moving average, 71.6% above their 200-day, and new highs still outpaced new lows, 33 to 5.